New Delhi: OPTM Healthcare has today unveiled its flagship clinic at South Extension, New Delhi, marking the beginning of the brand’s groundbreaking efforts to pioneer muscle-centric natural pain care. The launch event successfully demonstrated OPTM Healthcare’s renewed mission to bring forth practitioner-and-tech-led solutions for enabling pain-free living and optimizing one’s muscle health. The brand, which was earlier focused on comprehensive pain management for nearly all types of musculoskeletal disorders, has now pivoted strategically and has narrowed down its focus to only address knee osteoarthritis and spine degenerative disorders.
OPTM’s new clinic in New Delhi exemplifying its steadfast commitment to helping patients become pain-free by reversing their muscle age is spread over a vast 3500 sq. ft area. Equipped and integrated with cutting-edge tools and technologies and in-house diagnostic labs, the clinic boasts a superlative range of services and spaces designed to carry out optimal diagnosis, pain management, and transformative care.
Notably, at the heart of the clinic’s offerings is OPTM’s ‘Bio-Musculo Index’ – a diagnostic innovation backed by several years of clinical research, and developed and marketed by Varco Leg Care – India’s leading consumer health tech brand dedicated to leg care, which was also demonstrated today. This AI-enabled precision testing device powered by Varco, a first-of-its-kind in the entire world, grades muscle health by analyzing 10 different biomarkers, and thereafter using a proprietary AI algorithm, determines one’s muscle age and unlocks unparalleled insights for creating personalized treatment plans. Thereafter, OPTM’s effective phyto-topical formulations ’-based muscle-centric treatment protocol is being initiated, which entails a phydigital approach incorporating measurable and trackable progress milestones through a revolutionary motion sensing technology. The non-toxic, side-effects-free treatment process operates at the cellular level to reverse degeneration, eventually eliminating the recurring cycle of pain and reversing muscle age, thereby potentially eliminating the requirement for joint surgeries in many cases (especially for patients between stage 1 and stage 3).
Dr. Raghav Sehgal, PhD from Yale University, Director at Healthy Longevity Clinic USA & and Principal, of Longevity Tech Fund, and Dr. Michael Lim, Founder & CEO, of Cell Genesis (Singapore-based), who were present as chief guests, inaugurated the clinic. The attendees at this launch event were also introduced to OPTM’s signature, patent-pending evidence-based phytotherapy – a plant-based, 100% natural, non-invasive treatment methodology that has been clinically proven to reverse muscle aging by promoting cellular-level repair and restoration. In addition to OPTM’s flagship phytotherapy module, the clinic also features FDA-approved devices for implementing cryotherapy and lymphatic compression therapy, thus embracing a comprehensive approach to patient care. At the event, OPTM also announced its ambitious expansion plans to introduce 10 new clinics in the next 9 months, while also parallelly growing its team of domain experts, including certified physiotherapists, health coaches, Ayurvedic doctors and Orthopaedic surgeons.
Dr. Raghav Sehgal spoke at length about translating longevity science to clinical outcomes. On the other hand, Dr. Lim emphasized upon the pivotal role of improving muscle health in terms of extending human healthspan.
Suresh Jain, Anchor Investor, Sunicon Ventures and Managing Director at The Alan Scott Initiative, lauded OPTM Healthcare’s dedication towards delivering sustainable results and lasting impact by leveraging scientific aptitude and expertise, and spoke at length about how The Alan Scott Initiative is driving trailblazing innovations in the healthcare space with technology integration. “I am proud to support OPTM, an Alan Scott Initiative startup that is fostering innovations across the exciting domains of regenerative medicine, AI-enabled diagnosis, and phyto-therapeutics,” Suresh Jain added.
Notably, Dr. Apurba Ganguly, Founder, Chairman & Chief Scientist Officer of OPTM Healthcare is a veteran researcher, scientist and inventor. With his research spanning over three-and-a-half decades, he has established and verified the fact that the root cause of joint degeneration and pain lies in muscle weakness and muscle ageing – a revelation that paved the way for OPTM to embrace the revolutionary approach of root cause-oriented healing for sustainable results, as compared to traditional symptoms’-based pain relief processes followed till date by medical practitioners worldwide.
Speaking at the launch event, Dr. Apurba Ganguly said, “Since inception, our goal at OPTM Healthcare has been to empower individuals to reclaim their mobility and thrive. And by addressing the root causes of pain and degeneration, we are now are at the cusp of redefining what it means to live a healthy, active life, as we go beyond managing symptoms to tackling pain at its source. With the launch of our latest state-of-the-art clinic in the national capital, we are taking a pivotal step embarking on a journey to achieving an unmatchable track-record of treating patients with knee and spine degenerative disorders such as and lumbar spine and cervical issues. The new clinic embodies our vision and capabilities to usher a revolution and unprecedented transformation in pain management. Our disruptive approach heralds a future where natural, sustainable solutions can potentially either complement or at times replace invasive surgeries, restoring vitality, mobility, and longevity like never before.”
By integrating research-backed innovations with focussed interventions towards holistic pain care, OPTM aims to set a new benchmark in the healthcare industry, while working hand-in-hand with the medical practitioners’ ecosystem. Their new clinic represents a distinctive and future-ready platform heralding the brand’s journey to optimize pain management and muscle health, while aligning with its long-term vision of unlocking a longer, pain-free life for patients. The event concluded with an engaging demonstration of OPTM’s AI-powered biomarker test and a guided tour of the cutting-edge facility, leaving attendees inspired with the brand’s pathbreaking vision for revolutionizing the future of musculoskeletal healthcare and muscle-centric treatment.
About OPTM Healthcare
Imagine a world where pain is not just treated but understood, where AI and blood biomarkers redefine diagnosis and treatment of pain, giving patients solutions tailored to their unique needs. This is the future of healthcare, reimagined by us at OPTM.
We believe that healthy living isn’t just about managing pain – it’s about restoring effortless body movement, vitality, and freedom to live fully. Through advanced diagnostics, targeted therapies, and continuous care at our clinics, OPTM is empowering individuals to reclaim their mobility and thrive. With innovations across regenerative medicine, emerging-tech, and phyto-therapies, we are paving the way for a future where pain is no longer a barrier but a bridge to better health. We are certified by the Ministry of Ayush, Government of India and the European Medical Association and have presence across 3 Indian cities as of date.
Website: https://www.optmhealthcare.in
